Several studies on the treatment of lung cancer have shown that treatment strategies that reduce ALDH1 or target ALDH1 can reduce chemotherapeutic drug resistance and malignant proliferation of lung cancer. This evidence concerns the gene ALDH1A1 and lung carcinoma.